期刊文献+

铜绿假单胞菌对碳青霉烯类抗生素的耐药性 被引量:21

Carbapenems resistance and mechanism of Pseudomonas aeruginsa
下载PDF
导出
摘要 铜绿假单胞菌因其固有与获得性耐药,使抗菌药物的选择成为困惑医师的一大难题。碳青霉烯类抗生素由于其独特的抗菌优势受到临床医师的青睐,但随着使用的日益广泛,耐碳青霉烯类的铜绿假单胞菌也日益增多。铜绿假单胞菌对碳青霉烯类抗生素主要存在以下几种耐药机理:①β-内酰胺酶的水解作用(碳青霉烯酶、Am pC酶和ESBL s);②外膜通透性下降(O prD 2突变或缺失);③主动外排机制;④改变抗菌药物作用的靶位。铜绿假单胞菌对抗生素的耐药往往不是由单一因素造成的,且不同碳青霉烯类抗生素之间耐药机制存在差异。
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2005年第11期699-704,共6页 Chinese Journal of Antibiotics
  • 相关文献

参考文献35

  • 1Andrade S S, Jones R N, Gales A C, et al. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5year report of the SENTRY Antimicrobial Surveillance Program (1997 ~ 2001) [J]. J Antimicrob Chemother,2003,52(1) :140.
  • 2Patzer J, Toleman M A, Deshpande L M, et al. Pseudomonas aeruginosa strains harbouring an unusual blavuM-4gene cassette isolated from hospitalized children in Poland (1998~2001 ) [J]. J Antimicrob Chemother, 2004,53 (3):451.
  • 3王辉,陈民钧,中国医院内病原菌耐药监测网.1994~2001年中国重症监护病房非发酵糖细菌的耐药变迁[J].中华医学杂志,2003,83(5):385-390. 被引量:422
  • 4Troillet N, Samore M H, Carmeli Y, et al. Imipenemresistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility pattems [J]. Chin Infect Dis, 1997,25:1094.
  • 5Quinn J P, Dudek E J, DiVincenzo C A, et al. Emergence of resistance to imipenem during therapy of Pseudomonas aeruginosa infections [J]. J Infect Dis, 1986,154: 289.
  • 6Pournaras S, Maniati M, Petinaki E, et al. Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-[beta]-lactamase gene variants blaVIM-2 and blaVIM-4 [J]. J Antimicrob Chemother , 2003,51(6): 1409.
  • 7Yoneyama H, Nakae T. Mechanism of efficient elimination of protein D2[J]. Antimicrob Agents chemother, 1993,37(11):2385.
  • 8Suzuki Y, Matsumoto Y, Nishinari C, et al. Antimicrobial activities of meropenem against clinically isolated strains in 1997 [J]. Jpn J Antibiot,1999,52(12) :695.
  • 9Tsakris A, Pournaras S, Woodford N, et al. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece [J]. J Clin Microbiol,2000,38:1290.
  • 10Yan J J, Hsueh P R, Ko W C, et al. Metallo-β-Iactamases in clinical isolates in Taiwan and identification of VIM-3, a novel variant of VIM-2 enzyme [J].Antimicrob Agents Chemother , 2001,45 (8): 2224.

二级参考文献8

  • 1Itokazu GS, Quinn JP, Bell-Dixon C, et al. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive-care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis, 1996, 23: 779-784.
  • 2Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother, 1992, 29(suppl A): 19-24.
  • 3Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Psedomonas aeruginosa bacteriemia: outcome correlations in a prospective study of 200 patients. Am J Med, 1989, 87:540-546.
  • 4Lanson EL. Persistent carriage of gram-negative bacteria on hands. Am J Infect Control, 1981, 9: 112-119.
  • 5Urban C, Go E, Mariano N, et al. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis, 1993, 167: 448-451.
  • 6Ang SW, Lee ST. Emergence of a multiple-resistant strain of Acinetobacter in a bums unit. Ann Acad Med Singapore, 1992, 21:660-603.
  • 7Murray PR, Baron E J, Pfaller MA, et al. Manual of clinical laboratory.7th Edition. Washington DC: American Society for Microbiology, 1999,552-554.
  • 8Quinn JP. Clinical problem posed by multiresistant nonfermenting gramnegative pathogens. Clin Infect Dis, 1998, 27(Suppl 1 ): S117-124.

共引文献421

同被引文献165

引证文献21

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部